Ontology highlight
ABSTRACT: AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas.
PROVIDER: PRJNA261341 | ENA |
REPOSITORIES: ENA
ACCESS DATA